CASI Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for cancer and other serious diseases. Headquartered in Rockville, Maryland, the company strategically targets both the burgeoning Chinese market and global healthcare opportunities, leveraging its advanced research capabilities to meet significant unmet medical needs. With a robust pipeline of targeted therapies, CASI is well-positioned to capitalize on the increasing demand for novel treatment options in a rapidly evolving market.